mupirocin

mupirocin (APO-MUPIROCIN) is an FDA-listed pharmaceutical active ingredient. Associated with GlaxoSmithKline. Route of administration: topical. Current US regulatory status: approved.

APO-MUPIROCIN is a marketed brand name for mupirocin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

mupirocin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.